Covered recipient · General Payments record
OUMAYA ZLITNI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2024
$755.31
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $755.31 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $146.62 | 1 |
| Teva Pharmaceuticals USA, Inc. | $134.73 | 2 |
| Noven Pharmaceuticals, Inc. | $124.98 | 1 |
| Alkermes, Inc. | $115.79 | 1 |
| E.R. Squibb & Sons, L.L.C. | $106.34 | 1 |
| ABBVIE INC. | $103.26 | 1 |
| Corium, Inc. | $23.59 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $755.31 | 8 |
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $103.26 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106399995 | CMS |
| Alkermes, Inc. | $115.79 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120625637 | CMS |
| Corium, LLC | $23.59 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100210722 | CMS |
| E.R. Squibb & Sons, L.L.C. | $106.34 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101438224 | CMS |
| Janssen Pharmaceuticals, Inc | $146.62 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077979386 | CMS |
| Noven Pharmaceuticals, Inc. | $124.98 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084817122 | CMS |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151536449 | CMS |
| Teva Pharmaceuticals USA, Inc. | $9.73 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151536485 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.